CRISM Therapeutics (CRTX) Competitors GBX 10 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors CRTX vs. FAR, KAV, BRES, LND, BMN, FRG, TGR, BEM, CMET, and ATNShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Ferro-Alloy Resources (FAR), Kavango Resources (KAV), Blencowe Resources (BRES), Landore Resources (LND), Bushveld Minerals (BMN), Firering Strategic Minerals (FRG), Tirupati Graphite (TGR), Beowulf Mining (BEM), Capital Metals (CMET), and Aterian (ATN). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Ferro-Alloy Resources Kavango Resources Blencowe Resources Landore Resources Bushveld Minerals Firering Strategic Minerals Tirupati Graphite Beowulf Mining Capital Metals Aterian CRISM Therapeutics (LON:CRTX) and Ferro-Alloy Resources (LON:FAR) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, community ranking, analyst recommendations, valuation and media sentiment. Does the media refer more to CRTX or FAR? In the previous week, CRISM Therapeutics' average media sentiment score of 0.00 equaled Ferro-Alloy Resources'average media sentiment score. Company Overall Sentiment CRISM Therapeutics Neutral Ferro-Alloy Resources Neutral Which has more risk & volatility, CRTX or FAR? CRISM Therapeutics has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Ferro-Alloy Resources has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Do institutionals & insiders have more ownership in CRTX or FAR? 1.5% of Ferro-Alloy Resources shares are owned by institutional investors. 68.8% of CRISM Therapeutics shares are owned by insiders. Comparatively, 50.9% of Ferro-Alloy Resources shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community favor CRTX or FAR? CRISM Therapeutics and Ferro-Alloy Resources both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCRISM TherapeuticsN/AN/AFerro-Alloy ResourcesOutperform VotesNo VotesUnderperform Votes16100.00% Which has stronger earnings & valuation, CRTX or FAR? CRISM Therapeutics has higher earnings, but lower revenue than Ferro-Alloy Resources. Ferro-Alloy Resources is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCRISM TherapeuticsN/AN/A-£1.77M£8.221.22Ferro-Alloy Resources£4.55M2.66-£7.71M-£0.01-250.00 Is CRTX or FAR more profitable? CRISM Therapeutics has a net margin of 0.00% compared to Ferro-Alloy Resources' net margin of -169.46%. CRISM Therapeutics' return on equity of -62.67% beat Ferro-Alloy Resources' return on equity.Company Net Margins Return on Equity Return on Assets CRISM TherapeuticsN/A -62.67% -26.77% Ferro-Alloy Resources -169.46%-77.73%-21.47% Do analysts rate CRTX or FAR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CRISM Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AFerro-Alloy Resources 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryCRISM Therapeutics beats Ferro-Alloy Resources on 7 of the 10 factors compared between the two stocks. Ad Porter & CompanyTicking time bomb. Detonation Nov 5Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£3.27M£894.15M£2.76B£1.40BDividend YieldN/A6.43%5.23%11.77%P/E Ratio1.2286.10121.411,584.23Price / SalesN/A55,327.56530,779.57214,277.95Price / CashN/A24.6923.4526.96Price / Book1.672.643.502.88Net Income-£1.77M£55.15M£143.37M£155.21M7 Day Performance-9.09%-1.09%-0.70%0.54%1 Month Performance11.11%0.35%0.80%-0.39%1 Year PerformanceN/A32.12%23.74%103.11% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 10flatN/AN/A£3.27MN/A1.224Gap DownFARFerro-Alloy ResourcesN/AGBX 2.55flatN/A-73.2%£12.32M£4.55M-255.001,000KAVKavango ResourcesN/AGBX 0.78-3.1%N/A-7.7%£12.09MN/A-3.1943Gap DownBRESBlencowe ResourcesN/AGBX 5+7.5%N/A-0.5%£11.32MN/A-500.003Gap UpLNDLandore ResourcesN/AGBX 3.40-1.4%N/A-54.8%£10.64MN/A-340.006BMNBushveld MineralsN/AGBX 0.40+8.1%N/A-71.3%£9.24M£107.92M-6.67758Gap UpFRGFirering Strategic MineralsN/AGBX 4.75+6.7%N/A-3.9%£8.75M£1.61M-158.33N/AGap UpHigh Trading VolumeTGRTirupati GraphiteN/AGBX 6.25flatN/AN/A£8.09M£4.96M104.1736,000Gap UpBEMBeowulf MiningN/AGBX 20flatN/A+1,328.6%£7.77M£173.31M-285.7113Gap UpCMETCapital MetalsN/AGBX 1.90flatN/A-50.2%£6.55MN/A-1.9322Gap DownATNAterianN/AGBX 49flatN/A+5,284.6%£5.72MN/A-700.0022 Related Companies and Tools Related Companies Ferro-Alloy Resources Alternatives Kavango Resources Alternatives Blencowe Resources Alternatives Landore Resources Alternatives Bushveld Minerals Alternatives Firering Strategic Minerals Alternatives Tirupati Graphite Alternatives Beowulf Mining Alternatives Capital Metals Alternatives Aterian Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CRTX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
